CINECA IRIS Institutional Research Information System

MOTTA, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.205
EU - Europa 1.332
AS - Asia 830
SA - Sud America 124
AF - Africa 106
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 7
Totale 4.629
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.118
CN - Cina 348
IT - Italia 307
SE - Svezia 138
FR - Francia 111
DK - Danimarca 110
IN - India 96
IE - Irlanda 88
GB - Regno Unito 86
DE - Germania 83
ID - Indonesia 68
ES - Italia 66
AT - Austria 64
BR - Brasile 64
FI - Finlandia 52
KR - Corea 49
SG - Singapore 43
CA - Canada 41
ZA - Sudafrica 41
VN - Vietnam 39
JP - Giappone 36
PL - Polonia 36
MX - Messico 35
NL - Olanda 35
RU - Federazione Russa 30
TH - Thailandia 30
RO - Romania 29
PK - Pakistan 24
AU - Australia 21
BE - Belgio 19
CO - Colombia 18
PE - Perù 18
TR - Turchia 17
UA - Ucraina 17
AR - Argentina 15
TW - Taiwan 15
CH - Svizzera 13
HK - Hong Kong 12
IR - Iran 12
PH - Filippine 10
SK - Slovacchia (Repubblica Slovacca) 10
ML - Mali 9
SN - Senegal 9
GM - Gambi 7
PT - Portogallo 7
EU - Europa 6
HU - Ungheria 6
MY - Malesia 6
UG - Uganda 6
CZ - Repubblica Ceca 5
EG - Egitto 5
KE - Kenya 5
NO - Norvegia 5
AE - Emirati Arabi Uniti 4
ET - Etiopia 4
JO - Giordania 4
NZ - Nuova Zelanda 4
TN - Tunisia 4
BH - Bahrain 3
CL - Cile 3
EC - Ecuador 3
HN - Honduras 3
IL - Israele 3
LV - Lettonia 3
BG - Bulgaria 2
BO - Bolivia 2
BT - Bhutan 2
BY - Bielorussia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GH - Ghana 2
GR - Grecia 2
GT - Guatemala 2
HR - Croazia 2
IQ - Iraq 2
LU - Lussemburgo 2
MA - Marocco 2
PA - Panama 2
SD - Sudan 2
TZ - Tanzania 2
AP - ???statistics.table.value.countryCode.AP??? 1
CF - Repubblica Centrafricana 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
GF - Guiana Francese 1
GN - Guinea 1
KZ - Kazakistan 1
LS - Lesotho 1
LY - Libia 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
MW - Malawi 1
NA - Namibia 1
NG - Nigeria 1
QA - Qatar 1
SV - El Salvador 1
Totale 4.629
Salva come PNG Salva come JPEG
Città #
Ann Arbor 308
Chandler 212
Beijing 144
Fairfield 138
Redwood City 120
Houston 100
Torino 87
Dublin 84
Woodbridge 82
Wilmington 76
Ashburn 72
Vienna 58
Nyköping 52
Villeurbanne 47
Seattle 46
Dearborn 41
Pisa 40
Cambridge 34
Singapore 31
Princeton 29
Medford 28
Shanghai 28
Warsaw 28
Guangzhou 24
Jakarta 20
Jacksonville 19
Fremont 18
Tariceni 18
Ottawa 17
Boston 16
Nanjing 16
Chicago 14
Lima 14
Milan 14
Dong Ket 13
Brussels 12
Hangzhou 12
Cape Town 11
Hanoi 11
New York 11
Seoul 11
Taipei 11
Boardman 10
Paris 10
Toronto 10
Turin 10
Washington 10
Bamako 9
Fuzhou 9
Martin 9
Moscow 9
Omaha 9
San Diego 9
Tianjin 9
Bangkok 8
Bogotá 8
Kunming 8
Bangalore 7
Banjul 7
Brasília 7
Buffalo 7
Central District 7
Gurgaon 7
Helsinki 7
Mexico 7
Mumbai 7
New Delhi 7
Phoenix 7
Saint Louis 7
Santa Gertrudes 7
Bengaluru 6
Brescia 6
Chengdu 6
Delhi 6
Duncan 6
Los Angeles 6
Madrid 6
Munro 6
Palo Alto 6
São Paulo 6
Bergamo 5
Buenos Aires 5
Chennai 5
Memphis 5
Padova 5
Para 5
Rome 5
Silver Spring 5
Toulouse 5
Vicenza 5
Wynberg 5
Xian 5
Abu Dhabi 4
Amsterdam 4
Bilbao 4
Changsha 4
Charlottesville 4
Chongqing 4
Durban 4
Gainesville 4
Totale 2.547
Salva come PNG Salva come JPEG
Nome #
Pharmacokinetics and pharmacogenetics of anti-tubercular drugs: a tool for treatment optimization? 782
TB and COVID-19 co-infection: Rationale and aims of a global study 419
Elvitegravir/Cobicistat/Tenofovir/Emtricitabine Penetration in the Cerebrospinal Fluid of Three HIV-Positive Patients 341
Effect of SNPs in human ABCB1 on daptomycin pharmacokinetics in Caucasian patients. 331
High interpatient variability of raltegravir CSF concentrations in HIV-positive patients: a pharmacogenetic analysis. 309
A UPLC-MS-MS method for the simultaneous quantification of first-line antituberculars in plasma and in PBMCs 298
HIV-1 Very Low Level Viremia is Associated with Virological Failure in HAART-treated Patients 283
Cerebrospinal fluid viral load and neopterin in HIV-positive patients with undetectable viraemia 183
Molecular epidemiology of methicillin-resistant S. aureus in the ICU setting. 165
Anidulafungin versus fluconazole: clinical focus on IDSA and ESCMID guidelines. 164
The Influence of Pharmacogenetic Variants in HIV/Tuberculosis Co-infected Patients in Uganda in the SOUTH Study 161
Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis 152
Tenofovir Plasma Concentrations According to Companion Drugs: a Cross-sectional Study in HIV-positive Patients with Normal Renal Function. 145
Role of vitamin D pathway gene polymorphisms on rifampicin plasma and intracellular pharmacokinetics 131
Ethambutol plasma and intracellular pharmacokinetics: A pharmacogenetic study 110
Undetectable antimicrobial plasma concentrations in an HIV-positive patient with protein-losing enteropathy and chylothorax during Mycobacterium genavense and Leishmania abdominal infections 105
Wound botulism after traumatic open fracture in Italy 103
Erratum: A probable drug-to-drug interaction between voriconazole and haloperidol in a slow metabolizer of CYP2C19 patient 97
Dried Plasma/Blood Spots for Monitoring Antiretroviral Treatment Efficacy and Pharmacokinetics: a Cross-sectional Study in Rural Burundi. 92
Level of HIV Viremia Below 50 copies/ml Predicts Virologic Rebound in HAART-treated Patients 68
Early low-molecular-weight heparin administration is associated with shorter time to SARS-CoV-2 swab negativity 67
Pharmacokinetics of first-line antitubercular drugs in plasma and PBMCs 64
Economic impact of antifungal treatment in IFD by Candida species: Anidulafungin administration as a cost-effective alternative for critical care patients 59
A probable drug-to-drug interaction between voriconazole and haloperidol in a slow metabolizer of CYP2C19 58
Risk factors for mortality in patients with Staphylococcus aureus bloodstream infection 56
Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses? 41
The Effect of Rifampicin on Darunavir, Ritonavir, and Dolutegravir Exposure within Peripheral Blood Mononuclear Cells: a Dose Escalation Study 40
Low antituberculosis drug concentrations in HIV-tuberculosis-coinfected adults with low body weight: Is it time to update dosing guidelines? 32
Personalization Of Antitubercular Treatment: Evaluation Of Pharmacological Determinants Of Treatment Response 2
Totale 4.858
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.684
article - articoli 0
book - libri 0
conference - conferenze 220
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.904
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020761 0 49 38 76 78 137 74 69 47 66 50 77
2020/2021560 47 44 27 41 47 52 27 28 47 40 50 110
2021/20221.117 81 69 108 130 91 103 90 84 109 38 135 79
2022/2023633 61 66 14 57 63 138 26 48 67 28 35 30
2023/2024363 37 46 21 24 39 43 27 31 3 28 30 34
2024/202524 14 10 0 0 0 0 0 0 0 0 0 0
Totale 4.858